Tetra Radar · FDA Approvals · Decision date
VILTEPSO: FDA decision date
Entrada Therapeutics, Inc. (TRDA) · 28 February 2027
Sarepta submitted sNDAs in April 2026 seeking conversion of AMONDYS 45 and VYONDYS 53 to full approval (PDUFA of February 28, 2027).
Source: 10-Q of 5 November 2026
The decision is pending.
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.